Kura Oncology, Inc.KURANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+38.0%
5Y CAGR+32.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+38.0%/yr
vs +22.1%/yr prior
5Y CAGR
+32.0%/yr
Recent acceleration
Acceleration
+15.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $367.90M | +48.9% |
| 2024 | $247.08M | +49.8% |
| 2023 | $164.96M | +17.9% |
| 2022 | $139.87M | +6.6% |
| 2021 | $131.26M | +43.1% |
| 2020 | $91.70M | +35.9% |
| 2019 | $67.48M | +7.3% |
| 2018 | $62.88M | +74.3% |
| 2017 | $36.08M | +27.2% |
| 2016 | $28.37M | - |